Intermountain Healthcare genomics division awards $400K for precision medicine research

Intermountain Healthcare Precision Genomics in Murray, Utah, granted more than $400,000 to four translational research projects aimed toward advancing precision medicine.

Here are the four winners:  

1. Stanford (Calif.) University will design an algorithm to use in Intermountain Healthcare's patient records to determine an individual's risk for developing familial hypercholesterolemia.

2. Huntsman Cancer Institute and University of Utah School of Medicine in Salt Lake City will use breast cancer samples from Intermountain Healthcare to analyze genome areas predicted to contain genes susceptible to breast cancer. The organizations will also study genetic epidemiology of ovarian cancers in families that are high-risk for developing the disease.

3. Vivid Genomics, a company that helps pharmaceutical companies find patients for clinical trials, will sequence genomes of individuals with and without dementia to analyze predictors of Alzheimer's and other neurodegenerative diseases. The institutions will use Intermountain Healthcare's sequencing service, NGS ONE Genomic Services, to complete their research.

More articles on clinical leadership and infection control:
IU Health provides hands-on nurse training in escape room
Premier Safety Institute leader Gina Pugliese dies
Congo's Ebola outbreak surpasses 900 cases: 3 updates

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 


IC Database-3

Top 40 Articles from the Past 6 Months